Sökning: onr:"swepub:oai:DiVA.org:uu-531603" >
Ruxolitinib :
Ruxolitinib : A new hope for ventilator-induced diaphragm dysfunction
-
- Addinsall, Alex B. (författare)
- Karolinska Inst, Dept Physiol & Pharmacol, Basic & Clin Muscle Biol, Stockholm, Sweden.;Univ Copenhagen, Novo Nord Fdn Ctr Basic Metab Res, Copenhagen, Denmark.
-
- Cacciani, Nicola (författare)
- Karolinska Inst, Dept Physiol & Pharmacol, Basic & Clin Muscle Biol, Stockholm, Sweden.;Karolinska Inst, Ctr Mol Med, Stockholm, Sweden.
-
- Moruzzi, Noah (författare)
- Karolinska Institutet,Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, Dept Mol Med & Surg, Stockholm, Sweden.
-
visa fler...
-
- Akkad, Hazem (författare)
- Karolinska Inst, Dept Physiol & Pharmacol, Basic & Clin Muscle Biol, Stockholm, Sweden.
-
- Maestri, Alice (författare)
- Karolinska Institutet,Karolinska Inst, Ctr Mol Med, Stockholm, Sweden.;Karolinska Inst, Dept Med, Div Cardiovasc Med, Solna, Sweden.
-
- Berggren, Per-Olof (författare)
- Karolinska Institutet,Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, Dept Mol Med & Surg, Stockholm, Sweden.
-
- Widgren, Anna (författare)
- Uppsala universitet,Analytisk kemi
-
- Bergquist, Jonas (författare)
- Uppsala universitet,Analytisk kemi
-
- Tchkonia, Tamara (författare)
- Viron Mol Med Inst, Muscle Biol Program, Boston, MA USA.
-
- Kirkland, James L. (författare)
- Karolinska Institutet,Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA.;Mayo Clin, Div Gen Internal Med, Rochester, MN USA.,Karolinska Inst, Dept Physiol & Pharmacol, Basic & Clin Muscle Biol, Stockholm, Sweden.;Karolinska Inst, Ctr Mol Med, Stockholm, Sweden.;Viron Mol Med Inst, Muscle Biol Program, Boston, MA USA.;Karolinska Inst, Dept Physiol & Pharmacol, Basic & Clin Muscle Biol Grp, Solnavagen 9, S-17165 Solna, Sweden.
-
- Larsson, Lars (författare)
- Karolinska Inst, Dept Physiol & Pharmacol, Basic & Clin Muscle Biol, Stockholm, Sweden.;Karolinska Inst, Ctr Mol Med, Stockholm, Sweden.;Viron Mol Med Inst, Muscle Biol Program, Boston, MA USA.;Karolinska Inst, Dept Physiol & Pharmacol, Basic & Clin Muscle Biol Grp, Solnavagen 9, S-17165 Solna, Sweden.
-
visa färre...
-
Karolinska Inst, Dept Physiol & Pharmacol, Basic & Clin Muscle Biol, Stockholm, Sweden;Univ Copenhagen, Novo Nord Fdn Ctr Basic Metab Res, Copenhagen, Denmark. Karolinska Inst, Dept Physiol & Pharmacol, Basic & Clin Muscle Biol, Stockholm, Sweden.;Karolinska Inst, Ctr Mol Med, Stockholm, Sweden. (creator_code:org_t)
- John Wiley & Sons, 2024
- 2024
- Engelska.
-
Ingår i: Acta Physiologica. - : John Wiley & Sons. - 1748-1708 .- 1748-1716. ; 240:5
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://uu.diva-port... (primary) (Raw object)
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Aim: Mechanical ventilation (MV) results in diminished diaphragm size and strength, termed ventilator-induced diaphragm dysfunction (VIDD). VID increases dependence, prolongs weaning, and increases discharge mortality rates. The Janus kinase (JAK)/Signal Transducer and Activator of Transcription (STAT) pathway is implicated in VIDD, upregulated following MV. JAK/STAT inhibition alleviates chronic muscle wasting conditions. This study aimed to explore the therapeutic potential of Ruxolitinib, an FDA approved JAK1/2 inhibitor (JI) for the treatment of VIDD. Methods: Rats were subjected to 5 days controlled MV (CMV) with and without daily Ruxolitinib gavage. Muscle fiber size and function were assessed. RNAseq, mitochondrial morphology, respirometry, and mass spectrometry were determined. Results: CMV significantly reduced diaphragm size and specific force by 45% (p < 0.01), associated with a two-fold P-STAT3 upregulation (p < 0.001). CMV disrupted mitochondrial content and reduced the oxygen consumption rate (p < 0.01). Expression of the motor protein myosin was unaffected, however CMV alters myosin function via post-translational modifications (PTMs). Daily administration of JI increased animal survival (40% vs. 87%; p < 0.05), restricted P-STAT3 (p < 0.001), and preserved diaphragm size and specific force. JI was associated with preserved mitochondrial content and respiratory function (p < 0.01), and the reversal or augmentation of myosin deamidation PTMs of the rod and head region. Conclusion: JI preserved diaphragm function, leading to increased survival in an experimental model of VIDD. Functional enhancement was associated with maintenance of mitochondrial content and respiration and the reversal of ventilator-induced PTMs of myosin. These results demonstrate the potential of repurposing Ruxolitinib for treatment of VIDD.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Fysiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Physiology (hsv//eng)
Nyckelord
- critical care
- diaphragm
- mitochondria
- myosin
- post-translational modification
- STAT3
- VIDD
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Addinsall, Alex ...
-
Cacciani, Nicola
-
Moruzzi, Noah
-
Akkad, Hazem
-
Maestri, Alice
-
Berggren, Per-Ol ...
-
visa fler...
-
Widgren, Anna
-
Bergquist, Jonas
-
Tchkonia, Tamara
-
Kirkland, James ...
-
Larsson, Lars
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinska och f ...
-
och Fysiologi
- Artiklar i publikationen
-
Acta Physiologic ...
- Av lärosätet
-
Uppsala universitet
-
Karolinska Institutet